Integrated GST & Customs Control Framework for Pharmaceutical Industry

This framework establishes an integrated indirect tax control system for pharmaceutical companies by aligning GST and Customs across the full transaction lifecycle, from import to credit to supply to refund or reversal.

At its core, the framework ensures that every transaction tells a consistent story. Import valuation aligns with GST valuation and transfer pricing. Classification is supported by technical evidence. Contracts reflect actual conduct. Movement of goods is mirrored by tax documentation. Credits flow seamlessly and are supported by verifiable data trails.Very critical to have both form and substance to support any tax positions. 

The framework specifically addresses the high-risk areas as well that are frequently subject to scrutiny by authorities. These include related party imports, free samples and promotional schemes, clinical trials and R&D services, job work and loan licensing arrangements, expiry and destruction of goods, and refund structures.

It introduces critical control layers that are often overlooked in traditional reviews, time of supply, place of supply, contractual alignment, vendor risk management, and evidence architecture. These elements ensure that positions are not only technically correct but also defensible under investigation, where the burden shifts from interpretation to proof.

Equally, the framework embeds a governance structure through exposure mapping, litigation readiness, advance ruling strategy, and centralized documentation. This transforms indirect tax from a reactive compliance function into a proactive, intelligence-driven system, capable of anticipating risk, ensuring consistency across laws, and supporting strategic business decisions.

In essence, this is not a checklist, it is a defence mechanism, designed to ensure that every position taken by the organization can be substantiated, sustained, and successfully defended.